Alessandra Bosch/LinkedIn
Jul 22, 2026, 09:29
Alessandra Bosch: Presenting the Latest Evidence in Pediatric Anticoagulation at ISTH 2026
Alessandra Bosch, Attending Physician at Zurich Children’s Hospital, Clinician Scientist at University of Zurich, shared on LinkedIn:
”What a HOT week at ISTH 2026 in Paris!
Grateful for the chance and honour to give a state-of-the-art talk on periprocedural anticoagulation management in children, and to present our poster on real-world rivaroxaban use in children to such an engaged community.
But beyond the science, ISTH is always about the people!
Reconnecting with long-time colleagues, and making new connections that will turn into future collaborations.
Thank you to everyone who stopped by to chat, ask questions, or just say hello.
On to the next one.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery